Lazard Asset Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $372K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $0 | Sell |
|
|||||
|
2024
Q3 | $80K | Buy |
|
|||||
|
2024
Q2 | $0 | Sell |
|
|||||
|
2024
Q1 | $36K | Sell |
|
|||||
|
2023
Q4 | $205K | Buy |
|
|||||
|
2023
Q3 | $41K | Buy |
|
|||||
|
2023
Q2 | $48K | Sell |
|
|||||
|
2023
Q1 | $114K | Sell |
|
|||||
|
2022
Q4 | $208K | Sell |
|
|||||
|
2022
Q3 | $270K | Buy |
|
|||||
|
2022
Q2 | $240K | Buy |
|
|||||
|
2022
Q1 | $218K | Buy |
|
|||||
|
2021
Q4 | $66K | Sell |
|
|||||
|
2021
Q3 | $160K | Buy |
|
|||||
|
2021
Q2 | $98K | Buy |
|
|||||
|
2021
Q1 | $1K | Sell |
|
|||||
|
2020
Q4 | $79K | Buy |
|
|||||
|
2020
Q3 | $38K | Sell |
|
|||||
|
2020
Q2 | $72K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $61K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.36M | Buy |
|